4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Genflow Biosciences plc (GENF) operates in the Biotechnology industry and is headquartered in London, United Kingdom with about 5 employees. Its market capitalization is roughly £12 million. In the fiscal year ended 2025-12-31, GENF reported £0M in revenue and (£1M) in net income.
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapies in the United Kingdom, Belgium, and the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | £0M | £0M | £0M | £0M | — |
| Operating Income (EBIT) | (£1M) | (£2M) | (£2M) | (£1M) | — |
| Net Income | (£1M) | (£2M) | (£2M) | (£1M) | — |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | £0M | £0M | £1M | £3M |
| Total Liabilities | £1M | £1M | £1M | £0M |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GENF viewer.
About TickerBase · Data methodology & sources · Privacy · Terms